The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

Share Price Information for Benchmark Holdings (BMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.00
Bid: 44.50
Ask: 45.30
Change: -3.00 (-6.25%)
Spread: 0.80 (1.798%)
Open: 44.60
High: 46.00
Low: 44.60
Prev. Close: 48.00
BMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Renewal of Sales and Marketing Agreement

22 Aug 2017 07:00

RNS Number : 6013O
Benchmark Holdings PLC
22 August 2017
 

 

Benchmark Holdings plc("Benchmark" or the "Company")

 

Benchmark secures renewal of key strategic sales and marketing agreement with Great Salt Lake artemia cooperative

 

Benchmark announces that its wholly owned subsidiary, INVE Aquaculture Holding BV (INVE), has successfully renewed its sales and marketing agreement with the Great Salt Lake Brine Shrimp Cooperative, Inc (GSL COOP). Under this long-term agreement, the Benchmark group maintains its rights to distribute a substantial share of the GSL COOP's harvest of artemia from the Great Salt Lake, Utah, the world's greatest source of brine shrimp, a natural live food widely used by the aquaculture industry in early stage nutrition.

 

Historically, artemia supplied under the sales and marketing agreement has represented approximately 60% of INVE's total artemia sales, and generated revenues of over £30m in 2016. The renewal of the sales and marketing agreement secures the Company long-term access to the world's top quality artemia, which, as well as providing significant revenues from direct sales, creates demand pull for INVE's portfolio of aquaculture hatchery feeds and health products.

 

Alongside continuation of the sales and marketing agreement, INVE has entered into a similarly long-term distribution agreement with the GSL COOP for INVE's current and future artemia-related products and technologies. INVE is developing a range of breakthrough artemia-related feed products, which are on track to be launched in early 2020. The distribution agreement with the GSL COOP provides Benchmark with access to additional distribution channels and customers for INVE's artemia-related products, and will contribute to growth in sales from 2020 onwards.

 

Both the sales and marketing agreement and the distribution agreement have an initial 10 year term. Under the sales and marketing agreement GSL COOP has a 5 year break clause in certain circumstances related to new product development.

 

Benchmark CEO Malcolm Pye commented:

 

"We are extremely pleased to be continuing with and building on our important relationship with the GSL COOP. The sales and marketing agreement secures long-term access to the best quality artemia available globally, from a responsibly and sustainably harvested source. Access to the GSL COOP's customer base will compliment Benchmark's existing distribution networks for its developing artemia-related product portfolio, and is expected to create significant growth in sales across the Advanced Animal Nutrition division in the years to come."

 

 

-ENDS-

 

Benchmark Holdings plc

Tel: 020 7920 3150

Malcolm Pye, CEO

Rachel Aninakwah, Communications

Numis

Tel: 020 7260 1000

Michael Meade / Freddie Barnfield (NOMAD)

James Black (Corporate Broking)

Tavistock

Tel: 020 7920 3150

Niall Walsh / Sophie Praill / Simon Hudson

 

 

Notes to Editors:

Benchmark challenges the status quo in aquaculture, agriculture and animal healthcare.

 

Since 2000, Benchmark has consistently worked to build a platform to serve its customers, helping farmers to take control of their biological environment through the combination of genetics, nutrition, health and knowledge services. Through its in-depth knowledge of animal biology Benchmark is able to tackle the key issues in the aquaculture, livestock and companion animal sectors.

 

The Company has proven distribution capabilities in high growth markets and operates internationally with R&D facilities, commercial farms, diagnostic laboratories, manufacturing sites, production facilities and commercial offices across 27 countries in five continents. As at 30 June 2017, Benchmark employed 951 people. 

 

For further information on Benchmark please visit www.benchmarkplc.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGUUWRUPMUGP
Date   Source Headline
26th Apr 20244:18 pmRNSForm 8.3 - BENCHMARK HOLDINGS PLC
26th Apr 20241:54 pmRNSNotice of Q2 and Interim Results
25th Apr 20247:00 amRNSForm 8.3 - BENCHMARK HOLDINGS PLC
23rd Apr 202410:44 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
23rd Apr 20247:00 amRNSRule 2.9 Announcement
22nd Apr 202410:42 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
19th Apr 20249:23 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
18th Apr 202410:37 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
17th Apr 20244:13 pmRNSFORM 8.3 - BENCHMARK HOLDINGS PLC
17th Apr 202410:27 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
16th Apr 20249:54 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
11th Apr 202410:51 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
8th Apr 202411:26 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
5th Apr 202410:38 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
5th Apr 20249:23 amRNSForm 8.3 - Benchmark Holdings plc
28th Mar 202412:00 pmRNSTotal Voting Rights
22nd Mar 202411:51 amRNSForm 8.3 - Benchmark Holdings plc
22nd Mar 202410:52 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
22nd Mar 202410:33 amRNSBENCHMARK Holdings PLC
21st Mar 20249:58 amRNSForm 8.3 - Benchmark Holdings plc
21st Mar 20247:00 amRNSBlock Listing Six Monthly Return
20th Mar 202411:28 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
19th Mar 202410:01 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
15th Mar 202411:13 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
7th Mar 202411:26 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
7th Mar 20247:00 amRNSRule 2.9 Announcement
6th Mar 202410:36 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
5th Mar 202411:10 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
4th Mar 20243:13 pmGNWForm 8.3 - [BENCHMARK HOLDINGS PLC - 01 03 2024] - (CGAML)
4th Mar 202411:22 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
29th Feb 202411:19 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
29th Feb 20247:00 amRNSTotal Voting Rights
27th Feb 202411:24 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
26th Feb 202411:06 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
23rd Feb 202411:23 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
22nd Feb 20243:15 pmRNSForm 8.3 - BENCHMARK HOLDINGS PLC
21st Feb 202411:24 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
20th Feb 202411:40 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
19th Feb 202410:59 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
16th Feb 202410:26 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
15th Feb 20247:00 amRNSQ1 Results
14th Feb 202411:37 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
8th Feb 20244:00 pmRNSResult of AGM
6th Feb 20244:08 pmRNSForm 8.3 - Benchmark Holdings PLC
6th Feb 20247:36 amRNSForm 8.3 - Benchmark Holdings PLC
5th Feb 20245:30 pmRNSRule 2.9 Announcement
5th Feb 20242:50 pmRNSForm 8.3 - Benchmark Holdings PLC
5th Feb 202410:20 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
1st Feb 202410:26 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
1st Feb 202410:16 amRNSForm 8.3 - Benchmark Holdings plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.